337 related articles for article (PubMed ID: 36138154)
1. Long-term neurologic outcomes of COVID-19.
Xu E; Xie Y; Al-Aly Z
Nat Med; 2022 Nov; 28(11):2406-2415. PubMed ID: 36138154
[TBL] [Abstract][Full Text] [Related]
2. Risks and burdens of incident dyslipidaemia in long COVID: a cohort study.
Xu E; Xie Y; Al-Aly Z
Lancet Diabetes Endocrinol; 2023 Feb; 11(2):120-128. PubMed ID: 36623520
[TBL] [Abstract][Full Text] [Related]
3. Acute and postacute sequelae associated with SARS-CoV-2 reinfection.
Bowe B; Xie Y; Al-Aly Z
Nat Med; 2022 Nov; 28(11):2398-2405. PubMed ID: 36357676
[TBL] [Abstract][Full Text] [Related]
4. Risks of mental health outcomes in people with covid-19: cohort study.
Xie Y; Xu E; Al-Aly Z
BMJ; 2022 Feb; 376():e068993. PubMed ID: 35172971
[TBL] [Abstract][Full Text] [Related]
5. Risks and burdens of incident diabetes in long COVID: a cohort study.
Xie Y; Al-Aly Z
Lancet Diabetes Endocrinol; 2022 May; 10(5):311-321. PubMed ID: 35325624
[TBL] [Abstract][Full Text] [Related]
6. Long COVID after breakthrough SARS-CoV-2 infection.
Al-Aly Z; Bowe B; Xie Y
Nat Med; 2022 Jul; 28(7):1461-1467. PubMed ID: 35614233
[TBL] [Abstract][Full Text] [Related]
7. Neurological Sequelae of COVID-19.
Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
[TBL] [Abstract][Full Text] [Related]
8. Neurologic manifestations associated with COVID-19: a multicentre registry.
Meppiel E; Peiffer-Smadja N; Maury A; Bekri I; Delorme C; Desestret V; Gorza L; Hautecloque-Raysz G; Landre S; Lannuzel A; Moulin S; Perrin P; Petitgas P; SellaI F; Wang A; Tattevin P; de Broucker T;
Clin Microbiol Infect; 2021 Mar; 27(3):458-466. PubMed ID: 33189873
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner.
Valderas C; Méndez G; Echeverría A; Suarez N; Julio K; Sandoval F
World J Pediatr; 2022 Jun; 18(6):373-382. PubMed ID: 35476245
[TBL] [Abstract][Full Text] [Related]
10. A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City.
Frontera JA; Sabadia S; Lalchan R; Fang T; Flusty B; Millar-Vernetti P; Snyder T; Berger S; Yang D; Granger A; Morgan N; Patel P; Gutman J; Melmed K; Agarwal S; Bokhari M; Andino A; Valdes E; Omari M; Kvernland A; Lillemoe K; Chou SH; McNett M; Helbok R; Mainali S; Fink EL; Robertson C; Schober M; Suarez JI; Ziai W; Menon D; Friedman D; Friedman D; Holmes M; Huang J; Thawani S; Howard J; Abou-Fayssal N; Krieger P; Lewis A; Lord AS; Zhou T; Kahn DE; Czeisler BM; Torres J; Yaghi S; Ishida K; Scher E; de Havenon A; Placantonakis D; Liu M; Wisniewski T; Troxel AB; Balcer L; Galetta S
Neurology; 2021 Jan; 96(4):e575-e586. PubMed ID: 33020166
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Infection and Risk of Postacute Psychiatric and Neurologic Diagnoses: A Nationwide Danish Cohort Study.
Nielsen NM; Spiliopoulos L; Hansen JV; Videbech P; Hviid A
Neurology; 2024 Mar; 102(5):e208113. PubMed ID: 38382013
[TBL] [Abstract][Full Text] [Related]
12. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.
Taquet M; Geddes JR; Husain M; Luciano S; Harrison PJ
Lancet Psychiatry; 2021 May; 8(5):416-427. PubMed ID: 33836148
[TBL] [Abstract][Full Text] [Related]
13. Acute Neurologic Manifestations of Respiratory Viruses.
Pizzi MA
Continuum (Minneap Minn); 2021 Oct; 27(5):1365-1381. PubMed ID: 34618764
[TBL] [Abstract][Full Text] [Related]
14. COVID-19: A Global Threat to the Nervous System.
Koralnik IJ; Tyler KL
Ann Neurol; 2020 Jul; 88(1):1-11. PubMed ID: 32506549
[TBL] [Abstract][Full Text] [Related]
15. Long-term cardiovascular outcomes of COVID-19.
Xie Y; Xu E; Bowe B; Al-Aly Z
Nat Med; 2022 Mar; 28(3):583-590. PubMed ID: 35132265
[TBL] [Abstract][Full Text] [Related]
16. Historical Perspectives on the Neurologic Manifestations of Viral Pandemics.
Holroyd KB; Berkowitz AL
Semin Neurol; 2023 Apr; 43(2):187-194. PubMed ID: 37037211
[TBL] [Abstract][Full Text] [Related]
17. Long-term gastrointestinal outcomes of COVID-19.
Xu E; Xie Y; Al-Aly Z
Nat Commun; 2023 Mar; 14(1):983. PubMed ID: 36882400
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Approaches to the Neurologic Manifestations of COVID-19.
Graham EL; Koralnik IJ; Liotta EM
Neurotherapeutics; 2022 Sep; 19(5):1435-1466. PubMed ID: 35861926
[TBL] [Abstract][Full Text] [Related]
19. Neurologic aspects of coronavirus disease of 2019 infection.
Hassett CE; Frontera JA
Curr Opin Infect Dis; 2021 Jun; 34(3):217-227. PubMed ID: 33769966
[TBL] [Abstract][Full Text] [Related]
20. [Bifacial weakness with paresthesia – a rare Guillain–Barré syndrome subtype associated with SARS-CoV-2 infection].
Gaál T; Szeszák G; Torák G; Salacz P
Orv Hetil; 2021 Nov; 162(45):1803-1807. PubMed ID: 34747359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
